Lotus Pharmaceutical Co Ltd
TWSE:1795
Wall Street
Price Targets
Price Targets Summary
Lotus Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Lotus Pharmaceutical Co Ltd
is 444.21 TWD
with a low forecast of 353.5 TWD and a high forecast of 630 TWD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Lotus Pharmaceutical Co Ltd's stock price target?
Price Target
444.21
TWD
According to Wall Street analysts, the average 1-year price target for
Lotus Pharmaceutical Co Ltd
is 444.21 TWD
with a low forecast of 353.5 TWD and a high forecast of 630 TWD.
What is Lotus Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
28%
For the last 13 years the
compound annual growth rate for
Lotus Pharmaceutical Co Ltd's revenue is
31%.
The projected
CAGR
for the next 3 years is
28%.
What is Lotus Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
26%
The
compound annual growth rate
of Lotus Pharmaceutical Co Ltd's operating income for the next 3 years is
26%.
What is Lotus Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
22%
The
compound annual growth rate
of Lotus Pharmaceutical Co Ltd's net income for the next 3 years is
22%.
